Budget Impact Analysis of Molecular Lymph Node Staging Versus Conventional Histopathology Staging in Colorectal Carcinoma

dc.contributor.author
Diaz Mercedes, Sherley
dc.contributor.author
Archilla Sanz, Iván
dc.contributor.author
Camps, Jordi
dc.contributor.author
Lacy Fortuny, Antonio Ma. de
dc.contributor.author
Gorostiaga, Iñigo
dc.contributor.author
Momblan, Dulce
dc.contributor.author
Ibarzabal, Ainitze
dc.contributor.author
Maurel Santasusana, Joan
dc.contributor.author
Chic Ruché, Núria
dc.contributor.author
Bombí, Josep Antoni
dc.contributor.author
Balaguer Prunés, Francesc
dc.contributor.author
Castells Garangou, Antoni
dc.contributor.author
Aldecoa Ansórregui, Iban
dc.contributor.author
Borràs Andrés, Josep Maria
dc.contributor.author
Cuatrecasas Freixas, Miriam
dc.date.issued
2020-10-15T10:48:25Z
dc.date.issued
2020-10-15T10:48:25Z
dc.date.issued
2019-05-21
dc.date.issued
2020-10-15T10:48:25Z
dc.identifier
1175-5652
dc.identifier
https://hdl.handle.net/2445/171260
dc.identifier
690173
dc.identifier
31115896
dc.description.abstract
Background: The presence of lymph node (LN) metastasis is a critical prognostic factor in colorectal cancer (CRC) patients and is also an indicator for adjuvant chemotherapy. The gold standard (GS) technique for LN diagnosis and staging is based on the analysis of haematoxylin and eosin (H&E)-stained slides, but its sensitivity is low. As a result, patients may not be properly diagnosed and some may have local recurrence or distant metastases after curative-intent surgery. Many of these diagnostic and treatment problems could be avoided if the one-step nucleic acid amplification assay (OSNA) was used rather than the GS technique. OSNA is a fast, automated, standardised, highly sensitive, quantitative technique for detecting LN metastases. Objectives: The aim of this study was to assess the budget impact of introducing OSNA LN analysis in early-stage CRC patients in the Spanish National Health System (NHS). Methods: A budget impact analysis comparing two scenarios (GS vs. OSNA) was developed within the Spanish NHS framework over a 3-year time frame (2017-2019). The patient population consisted of newly diagnosed CRC patients undergoing surgical treatment, and the following costs were included: initial surgery, pathological diagnosis, staging, follow-up expenses, systemic treatment and surgery after recurrence. One- and two-way sensitivity analyses were performed. Results: Using OSNA instead of the GS would have saved 1,509,182, 6,854,501 and 10,814,082 during the first, second and third years of the analysis, respectively, because patients incur additional costs in later years, leading to savings of more than 19 million for the NHS over the 3-year time horizon. Conclusions: Introducing OSNA in CRC LN analysis may represent not only an economic benefit for the NHS but also a clinical benefit for CRC patients since a more accurate staging could be performed, thus avoiding unnecessary treatments.
dc.format
13 p.
dc.format
application/pdf
dc.language
eng
dc.publisher
Springer Nature Switzerland AG
dc.relation
Reproducció del document publicat a: https://doi.org/10.1007/s40258-019-00482-7
dc.relation
Applied Health Economics and Health Policy, 2019, vol. 17, num. 5, p. 655-667
dc.relation
https://doi.org/10.1007/s40258-019-00482-7
dc.rights
cc by-nc (c) Diaz Mercedes et al., 2019
dc.rights
http://creativecommons.org/licenses/by-nc/3.0/es/
dc.rights
info:eu-repo/semantics/openAccess
dc.source
Articles publicats en revistes (Ciències Clíniques)
dc.subject
Càncer colorectal
dc.subject
Histopatologia
dc.subject
Colorectal cancer
dc.subject
Pathological histology
dc.title
Budget Impact Analysis of Molecular Lymph Node Staging Versus Conventional Histopathology Staging in Colorectal Carcinoma
dc.type
info:eu-repo/semantics/article
dc.type
info:eu-repo/semantics/publishedVersion


Files in this item

FilesSizeFormatView

There are no files associated with this item.